BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Suffolk and North East Essex Integrated Care Board is looking for a system partner to provide a Covid Medicines Delivery Unit (CMDU).
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Integrated Care 24 Limited (IC24) | 03193182 | £209,457 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 3 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 1,080 days (≈3 yrs) | £240,000 £209,457 initial term | 3 | active |
Weightings from the notice.
Government spending data: This supplier has received £93,262,211 in 540 payments (over £25k) from NHS England, London Ambulance Service NHS Trust, Gloucestershire Health and Care NHS Foundation Trust, Sussex Police (2014-05-31 to 2026-02-25). View full payment history →
Changes the buyer published to this notice after it first appeared.
This is a Provider Selection Regime (PSR) confirmation of contract award notice.
This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. This contract has now been formally awarded using the competitive process.
Contract award date: 17th November 2025
The dates between which the services are intended to be provided are: 1st December 2025 to 30th November 2027
Lifetime value of the contract is anticipated to be: Value excluding VAT: £209,457
There was no review during the standstill period.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.